Media Call: Pfizer-BioNTech COVID-19 Vaccine Actions – 1/3/2022
Media Call: Pfizer-BioNTech COVID-19 Vaccine Actions – 1/3/2022
Join us for a media call to discuss the FDA’s amendment to the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to:– Expand the use of a single booster dose to include use in individuals 12 through 15 years of age.
– Shorten the time between the completion of primary vaccination of the Pfizer-BioNTech COVID-19 Vaccine and a booster dose to at least five months.
– Allow for a third primary series dose for certain immunocompromised children 5 through 11 years of age.
Acting FDA Commissioner Dr. Janet Woodcock and FDA's Center for Biologics Evaluation and Research Director Dr. Peter Marks will be taking questions.
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.